7 July 2026
Cardiogeni PLC
("Cardiogeni", "CGNI" or the "Company")
Director's Dealings
Cardiogeni (AQSE: CGNI), announces that it has been notified of the following transactions in ordinary shares in the Company undertaken by directors/persons discharging managerial responsibility (PDMRs), details of which are set out in the notification below.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1. Details of the person discharging managerial responsibilities / person closely associated | a) Name Darrin Disley | 2. Reason for the Notification | a) Position/status Executive Chairman | b) Initial notification / Amendment Initial notification | 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | a) Name Cardiogeni PLC | b) LEI 9845000F8F59ATZD8F92 | 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | a) Description of the Financial instrument, type of instrument Shares | ISIN GB00BTBLFC12 | b) Nature of the transaction Issue of shares in lieu of accrued remuneration | c) Price(s) and volume(s)
| d) Aggregated information: · Aggregated volume · Price 1,000,047 £100,004.70 | e) Date of the transaction 21/04/2026 | f) Place of the Transaction Outside trading venue |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1. Details of the person discharging managerial responsibilities / person closely associated | a) Name Sir Martin Evans | 2. Reason for the Notification | a) Position/status Director | b) Initial notification / Amendment Initial notification | 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | a) Name Cardiogeni PLC | b) LEI 9845000F8F59ATZD8F92 | 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | a) Description of the Financial instrument, type of instrument Shares | ISIN GB00BTBLFC12 | b) Nature of the transaction Issue of shares in lieu of accrued remuneration | c) Price(s) and volume(s)
| d) Aggregated information: · Aggregated volume · Price 1,083,340 £108,334 | e) Date of the transaction 21/04/2026 | f) Place of the Transaction Outside trading venue |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1. Details of the person discharging managerial responsibilities / person closely associated | a) Name Ajan Reginald | 2. Reason for the Notification | a) Position/status Director | b) Initial notification / Amendment Initial notification | 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | a) Name Cardiogeni PLC | b) LEI 9845000F8F59ATZD8F92 | 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | a) Description of the Financial instrument, type of instrument Shares | ISIN GB00BTBLFC12 | b) Nature of the transaction Issue of shares in lieu of accrued remuneration | c) Price(s) and volume(s)
| d) Aggregated information: · Aggregated volume · Price 3,351,860 £335,186 | e) Date of the transaction 21/04/2026 | f) Place of the Transaction Outside trading venue |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1. Details of the person discharging managerial responsibilities / person closely associated | a) Name Joanne Martin | 2. Reason for the Notification | a) Position/status Director | b) Initial notification / Amendment Initial notification | 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | a) Name Cardiogeni PLC | b) LEI 9845000F8F59ATZD8F92 | 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | a) Description of the Financial instrument, type of instrument Shares | ISIN GB00BTBLFC12 | b) Nature of the transaction Issue of shares in lieu of accrued remuneration | c) Price(s) and volume(s)
| d) Aggregated information: · Aggregated volume · Price 250,000 £25,000 | e) Date of the transaction 21/04/2026 | f) Place of the Transaction Outside trading venue |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1. Details of the person discharging managerial responsibilities / person closely associated | a) Name Lord James Bethell | 2. Reason for the Notification | a) Position/status Director | b) Initial notification / Amendment Initial notification | 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | a) Name Cardiogeni PLC | b) LEI 9845000F8F59ATZD8F92 | 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | a) Description of the Financial instrument, type of instrument Shares | ISIN GB00BTBLFC12 | b) Nature of the transaction Issue of shares in lieu of accrued remuneration | c) Price(s) and volume(s)
| d) Aggregated information: · Aggregated volume · Price 100,000 10,000 | e) Date of the transaction 21/04/2026 | f) Place of the Transaction Outside trading venue |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END NEXFLFSTDAIRIIR